A once-scrapped Alzheimer’s drug may work after all, new analyses suggest
At the highest doses, aducanumab slowed mental decline, the drug developer claims
By targeting sticky globs of amyloid (red) in the brains of people with Alzheimer’s, a new drug may offer a way to slow the disease’s spread.
Martin M. Rotker/Science Source
This article is only available to Science News subscribers.
Subscribers, enter your e-mail address to access our archives.
